Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha J McIntyre

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Kidney International Reports|August 19, 2024
Trend and Monitoring of Skin Autofluorescence in Patients Receiving HemodialysisNatasha J McIntyre
Current Opinion in Nephrology and Hypertension|October 23, 2008
How to measure proteinuria?Natasha J McIntyre, Maarten W Taal
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 24, 2012
Treatment needs and diagnosis awareness in primary care patients with chronic kidney diseaseNatasha J McIntyre, Richard Fluck, Chris McIntyre, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 3, 2011
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3Natasha J McIntyre, Richard J Fluck, Christopher W McIntyre, et al.
Nephron. Clinical Practice|September 17, 2011
Risk profile in chronic kidney disease stage 3: older versus younger patientsNatasha J McIntyre, Richard J Fluck, Christopher W McIntyre, et al.
Plos One|February 6, 2013
Determinants of arterial stiffness in chronic kidney disease stage 3Natasha J McIntyre, Richard J Fluck, Christopher W McIntyre, et al.
BMJ Open|August 26, 2017
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3Adam Shardlow, Natasha J McIntyre, Richard J Fluck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2019
Determinants of change in arterial stiffness over 5 years in early chronic kidney diseaseNatasha J McIntyre, Adam Shardlow, Richard J Fluck, et al.
Kidney International|January 17, 2014
The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney diseaseMaarten W Taal, Victoria Thurston, Natasha J McIntyre, et al.
Plos Medicine|September 21, 2016
Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort StudyAdam Shardlow, Natasha J McIntyre, Richard J Fluck, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Kidney International Reports|August 19, 2024
Trend and Monitoring of Skin Autofluorescence in Patients Receiving HemodialysisNatasha J McIntyre
Current Opinion in Nephrology and Hypertension|October 23, 2008
How to measure proteinuria?Natasha J McIntyre, Maarten W Taal
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 24, 2012
Treatment needs and diagnosis awareness in primary care patients with chronic kidney diseaseNatasha J McIntyre, Richard Fluck, Chris McIntyre, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 3, 2011
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3Natasha J McIntyre, Richard J Fluck, Christopher W McIntyre, et al.
Nephron. Clinical Practice|September 17, 2011
Risk profile in chronic kidney disease stage 3: older versus younger patientsNatasha J McIntyre, Richard J Fluck, Christopher W McIntyre, et al.
Plos One|February 6, 2013
Determinants of arterial stiffness in chronic kidney disease stage 3Natasha J McIntyre, Richard J Fluck, Christopher W McIntyre, et al.
BMJ Open|August 26, 2017
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3Adam Shardlow, Natasha J McIntyre, Richard J Fluck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2019
Determinants of change in arterial stiffness over 5 years in early chronic kidney diseaseNatasha J McIntyre, Adam Shardlow, Richard J Fluck, et al.
Kidney International|January 17, 2014
The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney diseaseMaarten W Taal, Victoria Thurston, Natasha J McIntyre, et al.
Plos Medicine|September 21, 2016
Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort StudyAdam Shardlow, Natasha J McIntyre, Richard J Fluck, et al.
Pageof 3